Antimicrobial therapy in neonatal intensive care unit

Giovanni Corsello, Gregorio Serra, Alessandro Borghesi, Chryssoula Tzialla, Mauro Stronati

Risultato della ricerca: Articlepeer review

38 Citazioni (Scopus)


Severe infections represent the main cause of neonatal mortality accounting for more than one million neonatal deaths worldwide every year. Antibiotics are the most commonly prescribed medications in neonatal intensive care units (NICUs) and in industrialized countries about 1% of neonates are exposed to antibiotic therapy. Sepsis has often nonspecific signs and symptoms and empiric antimicrobial therapy is promptly initiated in high risk of sepsis or symptomatic infants. However continued use of empiric broad-spectrum antibiotic treatment in the setting of negative cultures especially in preterm infants may not be harmless. The benefits of antibiotic therapy when indicated are clearly enormous, but the continued use of antibiotics without any microbiological justification is dangerous and only leads to adverse events. The purpose of this review is to highlight the inappropriate use of antibiotics in the NICUs, to exam the impact of antibiotic treatment in preterm infants with negative cultures and to summarize existing knowledge regarding the appropriate choice of antimicrobial agents and optimal duration of therapy in neonates with suspected or culture-proven sepsis in order to prevent serious consequences.
Lingua originaleEnglish
pagine (da-a)27-
Numero di pagine6
Stato di pubblicazionePublished - 2015

All Science Journal Classification (ASJC) codes

  • ???subjectarea.asjc.2700.2735???


Entra nei temi di ricerca di 'Antimicrobial therapy in neonatal intensive care unit'. Insieme formano una fingerprint unica.

Cita questo